Conversely, Sakurai and colleagues [18] found in a cohort of subjects with neurodegenerative diseases, including those with PD, that APOE4 carriers with slow gait had significantly smaller cerebral GMV that correlated to worsened cognition when compared to non-carriers with normal gait. This evidence concerns the gene APOE and Parkinson disease.